Q: It's easy for case managers to feel overwhelmed during the novel coronavirus (COVID-19) pandemic. The workload has been burdensome for the past year, and many case managers are not able to strike the important work-life balance. What are some recommendations for reducing some of the stress and anxiety that has built up over the past year?
Q: My organization is considering outsourcing our coding to an offshore company. Does HIPAA apply only to healthcare entities and business associates located within the United States? If so, what would happen if the offshore third party experiences a breach? What are the risks associated with this decision?
Q: Was there an Excludes note change for subcategory G93.4- (other and unspecified encephalopathy) for fiscal year 2021? If so, how will it change any ICD-10-CM reporting and reimbursement for toxic encephalopathy and metabolic encephalopathy going forward?
Q: With novel coronavirus (COVID-19) concerns still persisting, patients should be avoiding emergency department (ED) visits when possible. How can case managers help in this process?
Q: While no one has a crystal ball, I am wondering what changes we might be expecting in the near future as the new administration makes its mark. How might case management be impacted?
Q: I've noticed an increase in denials for diagnoses of gram-negative pneumonia. How can we ensure that our providers are accurately documenting the appropriate clinical indicators?
Q: Are there any newly implemented fiscal year 2021 ICD-10-CM codes for spontaneous cerebrospinal fluid leaks (CSF)? Can you review any background and possible new codes for this disorder?
